« Terug naar overzicht

Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better?

a systematic review and meta-analysis

Objective: To investigate the association of running participation and the dose of running with the risk of all-cause, cardiovascular and cancer mortality.

Design: Systematic review and meta-analysis.

Results: Fourteen studies from six prospective cohorts with a pooled sample of 232 149 participants were included. In total, 25 951 deaths were recorded during 5.5–35 year follow-ups. Our meta-analysis showed that running participation is associated with 27%, 30% and 23% lower risk of all-cause (pooled adjusted hazard ratio (HR)=0.73; 95% confidence interval (CI) 0.68 to 0.79), cardiovascular (HR=0.70; 95% CI 0.49 to 0.98) and cancer (HR=0.77; 95% CI 0.68 to 0.87) mortality, respectively, compared with no running. A meta-regression analysis showed no significant dose–response trends for weekly frequency, weekly duration, pace and the total volume of running.

Conclusion: Increased rates of participation in running, regardless of its dose, would probably lead to substantial improvements in population health and longevity. Any amount of running, even just once a week, is better than no running, but higher doses of running may not necessarily be associated with greater mortality benefits.

Uitgever(s):

Download(s)

Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? : a systematic review and meta-analysis

Download PDF

---

Auteur(s)

Klik op de auteur meer artikelen te zoeken van deze auteur.

Zeljko Pedisic
N. Shrestha
Stephanie Kovalchik
Emmanuel Stamatakis
Nucharapon Liangruenrom
Jozo Grgic
Sylvia Titze
Stuart Biddle
Adrian Bauman
Pekka Oja

---

Tags van dit artikel

Klik op de tag meer artikelen te zoeken met deze tag.

gezondheid
gezondheidseffecten
hardlopen

---